Population
Shaker K+ channels
Design
Preclinical
Authors
Loading...
Findings on Shaker K+ residues should not yet alter clinical blocker use; extends models of external Ba2+ binding in Kv channels.
In Shaker K+ channels, D447 contributes to an external Ba2+ binding site while T449 imposes a barrier to the access of that site.
Hurst et al. (1996) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: